Sildenafil Citrate NDC 80425-0503

Product information

Brand name (proprietary)

Sildenafil Citrate

Generic name (nonproprietary)

sildenafil citrate

Active ingredients

Sildenafil citrate — 100 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Advanced Rx of Tennessee, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209302

Marketing start

Mar 20, 2025

Listing expires

Dec 31, 2026

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 80425-0503_30cb703a-6916-b436-e063-6294a90a5608SPL ID 30cb703a-6916-b436-e063-6294a90a5608SPL set ID 30cb7d6a-ce40-c794-e063-6294a90a6861RxCUI 314229UNII BW9B0ZE037

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480425050301 followed by a unit qualifier and the quantity Copy

Package 80425-0503-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.